is semaglutide approved by fda The a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 Novo Nordisk's Ozempic® pill, the

Understanding that weight loss may take time or require additional treatments can help manage expectations and avoid frustration

Gallbladder and pancreatitis Gallstones were more common with semaglutide (about 2.6% vs 1.2% with placebo) in STEP, in line with rapid weight loss across all weight-loss interventions

Contact the compounding pharmacy that produced it

Key factors include baseline body weight, adherence to reduced-calorie diet and increased physical activity, presence of type 2 diabetes (which typically results in less weight loss), concurrent medications affecting appetite or metabolism, and individual tolerance to gastrointestinal side effects